MoneyThe story, in brief
Generare raises $23.2M to discover unknown molecules and advance new drugs
$23.2M. That's what AI biotech startup Generare just raised to discover molecules that have never existed before.
The KeyNews take
Why it matters
AI-powered drug discovery is attracting serious capital as biotech companies race to generate novel molecular data that could revolutionize pharmaceutical development timelines and success rates.
The key facts
6 to know$23.2M Series A funding round
€20 million raised
Founded in 2023
Co-led by Alven and Daphni
Paris-based biotechnology company
Uses AI for drug development and molecular discovery
Go to the source
SiliconAnglesiliconangle.com
Publisher excerpt: Generare Bioscience SAS, a Paris-based biotechnology company generating never-before-seen molecular data for drug development using artificial intelligence, announced today it has raised €20 million, about $23.3 million, in an early-stage funding round co-led by Alven and Daphni. All existing…